BioPET

Authors Jeremy Roth, Kathleen F. Kerr, Kehao Zhu

Last update 17 July 2018

Copyright license GNU General Public License, version 2.0, GNU General Public License, version 3.0

Software version identifier 0.1.0, 0.2.0, 0.2.1, PACKAGES.rds, 0.2.2

Description

Prognostic Enrichment is a clinical trial strategy of evaluating an intervention in a patient population with a higher rate of the unwanted event than the broader patient population (R. Temple (2010) <doi:10.1038/clpt.2010.233>). A higher event rate translates to a lower sample size for the clinical trial, which can have both practical and ethical advantages. This package is a tool to help evaluate biomarkers for prognostic enrichment of clinical trials.

Cites work

Enrichment of Clinical Study Populations

This page was built for software: BioPET